
Alpha Tau Medical Ltd. Ordinary Shares
DRTS
DRTS: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.
moreShow DRTS Financials
Recent trades of DRTS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DRTS's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
-
Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
-
Patent Title: Polymer coatings for brachytherapy devices Dec. 20, 2022
-
Patent Title: Method and device for radiotherapy Aug. 28, 2018
Federal grants, loans, and purchases
Followers on DRTS's company Twitter account
Number of mentions of DRTS in WallStreetBets Daily Discussion
Recent insights relating to DRTS
Recent picks made for DRTS stock on CNBC
ETFs with the largest estimated holdings in DRTS
Flights by private jets registered to DRTS